Lyell Immunopharma, Inc. (NASDAQ:LYEL) Financings

Lyell Immunopharma, Inc.

Financings

RaiseDate
Private placement of private placement
Update: US$80M · US$10.77 a share · Goldman Sachs +1
Dealers: Goldman Sachs, Leerink Partners
Buyers: ARCH Venture Partners; Adage Capital Management LP; Caligan Partners LP; RTW Investments
Use of proceeds: Extend cash runway into 2028, beyond the expected ronde-cel BLA submission and updated LYL273 clinical data
Nov 4, 2026
Private placement of common stock and/or pre-funded warrants
Announced: up to US$100M · US$13.32 a share
Use of proceeds: Fund two pivotal-stage clinical trials of LYL314 and working capital for other general corporate purposes
Jul 25, 2025

Read by 6ix AI from the company's releases